Our investigation reveals the collaborative involvement of the MAPK/NF-κB and AhR pathways in DNCB-induced AD-like skin inflammation and barrier dysfunction orchestrated by TSLP and periostin, effects substantially mitigated by I3C treatment. The gene discussed is NFKB1; the disease is dermatitis.